abvcpharma.com - ABVC Company profit before taxes, interest and amortization
ABVC BioPharma develops plant-based medicines dependent on test results and lacks pricing power due to its search for licensing partners. Cash EBITDA visualizes current profit trends, where the parameter has stabilized at 0.00. This micro-developer has no approved drugs and therefore relies entirely on investor capital with zero operating revenue.
ABVC BioPharma, Inc. (ABVC) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio ABVC BioPharma|ABVC - Long-Term Debt to Capital|Short-Term Debt to Capital ABVC BioPharma Inc.|ABVC - Company Aggregate Debts|Debt to Book Capitalization Ratio ABVC BioPharma|ABVC - Company Long-Term Liabilities|Company Short-Term Debt ABVC BioPharma|Quick Liquidity Indicator abvcpharma.com
- earnings and market ratios statistics:
ABVC - Net Income|Expected Net Income ABVC BioPharma|ABVC - P/E Multiple|Future Price to Earnings abvcpharma.com|ABVC - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio ABVC BioPharma|ABVC - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months ABVC BioPharma|ABVC - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months abvcpharma.com|ABVC - Earnings growth in current year|Expected earnings per share trend next year ABVC BioPharma
Summary company analytics:ABVC BioPharma, Inc (ABVC)
To minimize risks when selecting an asset, it is necessary to evaluate the business's ability to generate cash flow before depreciation and interest. This metric captures the actual balance of supply and demand, while the absolute profit from the core operations of ABVC BioPharma reflects the impact of high laboratory costs and a lack of mass sales, which keep the operating leverage at a negative level.
Competitor analysis for ABVC BioPharma
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos)|Operating profit EBITDA ANI Pharmaceuticals Inc ANIP|MannKind Corp. - Operating profit EBITDA|AMPH: Profit before payment of interest, taxes and amortization|PCRX (Pacira BioSciences) - Operating profit before deduction of amortization|SPRY (ars-pharma.com) - Profit before payment of interest, taxes and amortization|TBPH (Theravance Biopharma, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Aquestive Therapeutics Inc (AQST)|Operating profit before deduction of amortization SCPH (scPharmaceuticals Inc.)|TECX (tectonictx.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA TNXP (Tonix Pharmaceuticals)|SXT Pharmaceuticals - Profit before payment of interest, taxes and amortization|Eupraxia Pharma - Operating profit EBITDA|Operating income before deduction of amortization BioHarvest Sciences, Inc. BHST|Invizyne Technologies, Inc. (EXOZ) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Oramed Pharmaceuticals Inc. (ORMP)|Profit before payment of interest, taxes and amortization Entera Bio Ltd|ipatherapeutics.com - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CPIX|QNTM (Quantum BioPharma Ltd.) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA FGEN (FibroGen Corp)|Operating profit EBITDA Telomir Pharmaceuticals Corp TELO|RANI - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization SNYR (Synergy CHC Corp)|rallybio.com (RLYB) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Lexaria Bioscience Corp.|PULM (Pulmatrix Corp) - Operating profit EBITDA|Operating profit EBITDA Pheton|Operating profit EBITDA APM|Operating profit EBITDA lyratherapeutics.com (LYRA)|Operating profit EBITDA IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. - Profit before payment of interest, taxes and amortization|YCBD: Operating profit before deduction of amortization|PRFX: Profit before payment of interest, taxes and amortization|CYTO: Operating profit EBITDA|Operating profit before deduction of amortization lipella.com|Profit before payment of interest, taxes and amortization OptiNose|Pieris Pharmaceuticals Inc - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA PROC|PTPI (Petros Pharma) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA QLI (Qilian International)|Operating profit EBITDA acelyrin.com SLRN|TFFP - Profit before payment of interest, taxes and amortization
